Please use this identifier to cite or link to this item:
|Title:||Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.|
|Authors:||Jansen, P. A.|
Hollox, Edward J.
Tjabringa, G. S.
de Jongh, G. J.
van Vlijmen-Willems, I. M.
Bergboer, J. G.
van Rossum, M. M.
de Jong, E. M.
den Heijer, M.
Evers, A. W.
Armour, J. A.
Zeeuwen, P. L.
|Citation:||PLoS ONE, 2009, 4 (3), pp. e4725-e4725|
|Abstract:||Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis.|
|Appears in Collections:||Published Articles, Dept. of Genetics|
Files in This Item:
|journal.pone.0004725.pdf||Publisher version||287.26 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.